These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 14508595

  • 21. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP, Adragão PP, Santos KR, Morgado FB, Cavaco DM, Rossi R, Abecasis M, Neves JP, Bonhosrst D, Gomes JL, Gomes RS.
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [Abstract] [Full Text] [Related]

  • 22. The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators?
    Maron BJ, Olivotto I, Maron MS.
    Eur Heart J; 2006 Aug; 27(16):1895-7. PubMed ID: 16818455
    [No Abstract] [Full Text] [Related]

  • 23. [Not Available].
    Muggli B, Gruner C.
    Ther Umsch; 2016 Aug; 73(12):759-765. PubMed ID: 28462616
    [No Abstract] [Full Text] [Related]

  • 24. Septal reduction therapy for obstructive hypertrophic cardiomyopathy and sudden death: what statistics cannot tell you.
    Nishimura RA, Ommen SR.
    Circ Cardiovasc Interv; 2010 Apr; 3(2):91-3. PubMed ID: 20407109
    [No Abstract] [Full Text] [Related]

  • 25. Treating hypertrophic cardiomyopathy: two views.
    Salberg L.
    J Am Coll Cardiol; 2005 Dec 06; 46(11):2146; author reply 2146-7. PubMed ID: 16325059
    [No Abstract] [Full Text] [Related]

  • 26. Interventional treatments for hypertrophic cardiomyopathy.
    Mohiddin SA, Knight C.
    Cardiovasc Ther; 2012 Jun 06; 30(3):e107-14. PubMed ID: 21883992
    [Abstract] [Full Text] [Related]

  • 27. The science of uncertainty and the art of probability: syncope and its consequences in hypertrophic cardiomyopathy.
    Elliott P, McKenna W.
    Circulation; 2009 Apr 07; 119(13):1697-9. PubMed ID: 19349332
    [No Abstract] [Full Text] [Related]

  • 28. Triple type of obstruction in hypertrophic cardiomyopathy.
    Efthimiadis GK, Parcharidou DG, Vassilikos V, Giannakoulas G, Pliakos C, Parcharidis GE.
    J Cardiovasc Med (Hagerstown); 2008 Nov 07; 9(11):1156-8. PubMed ID: 18852593
    [No Abstract] [Full Text] [Related]

  • 29. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA, Rosenberg MA, Fifer MA, Palacios IF, Lowry PA, Ruskin JN, Sanborn DM, Picard MH, Vlahakes GJ, Mela T, Das S.
    Am J Cardiol; 2009 Jul 01; 104(1):128-32. PubMed ID: 19576333
    [Abstract] [Full Text] [Related]

  • 30. Hypertrophic cardiomyopathy. Pathophysiology, diagnosis, and treatment.
    Popjes ED, St John Sutton M.
    Geriatrics; 2003 Mar 01; 58(3):41-6; quiz 47. PubMed ID: 12650117
    [Abstract] [Full Text] [Related]

  • 31. Septal myectomy for obstructive hypertrophic cardiomyopathy.
    Dearani JA, Danielson GK.
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2005 Mar 01; ():86-91. PubMed ID: 15818363
    [Abstract] [Full Text] [Related]

  • 32. Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy.
    Lawrenz T, Obergassel L, Lieder F, Leuner C, Strunk-Mueller C, Meyer Zu Vilsendorf D, Beer G, Kuhn H.
    Pacing Clin Electrophysiol; 2005 Apr 01; 28(4):295-300. PubMed ID: 15826262
    [Abstract] [Full Text] [Related]

  • 33. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy.
    Cotiga D, Ehlert F, Sherrid M.
    Anadolu Kardiyol Derg; 2006 Dec 01; 6 Suppl 2():55-60. PubMed ID: 17162272
    [Abstract] [Full Text] [Related]

  • 34. Implantable defibrillators in hypertrophic cardiomyopathy.
    Grace A.
    Heart; 2009 May 01; 95(9):695-6. PubMed ID: 19282312
    [No Abstract] [Full Text] [Related]

  • 35. [Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy].
    Maron BJ.
    Rev Esp Cardiol; 2006 Jun 01; 59(6):527-30. PubMed ID: 16790193
    [No Abstract] [Full Text] [Related]

  • 36. Ten common questions about hypertrophic cardiomyopathy...and misconceptions.
    Maron BJ.
    Cardiol Rev; 2005 Jun 01; 13(2):59-60. PubMed ID: 15705254
    [No Abstract] [Full Text] [Related]

  • 37. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ, Greiss I, Talakic M, Guerra PG, Macle L, Thibault B, Dubuc M, Roy D.
    Can J Cardiol; 2005 Apr 01; 21(5):441-8. PubMed ID: 15861263
    [Abstract] [Full Text] [Related]

  • 38. Hypertrophic cardiomyopathy: an overview.
    Smith KM, Squiers J.
    Crit Care Nurs Clin North Am; 2013 Jun 01; 25(2):263-72. PubMed ID: 23692943
    [Abstract] [Full Text] [Related]

  • 39. Long-term survival of patients with resting obstructive hypertrophic cardiomyopathy: more questions than answers.
    Collins RT, Gossett JM, Swearingen CJ.
    J Am Coll Cardiol; 2012 May 08; 59(19):1730; author reply 1730-1. PubMed ID: 22554606
    [No Abstract] [Full Text] [Related]

  • 40. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M, Mohammadzadeh S, Taherpour M, Faghfurian B, Fazelifar AF, Alizadeh A, Rad MA, Sadr-Ameli MA.
    Europace; 2009 May 08; 11(5):643-9. PubMed ID: 19164362
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.